Asset
AUTOLOGOUS CULTURED CHONDROCYTES
Vericel Corporation Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03588975 | phase3 | recruiting | 2018-10-24 | 2030-02-01 | Vericel Corporation | A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 103661 | BLA | Vericel Corporation |
Marketed products (1)
- Carticel Sm Service